GR76861B - - Google Patents
Info
- Publication number
- GR76861B GR76861B GR69089A GR820169089A GR76861B GR 76861 B GR76861 B GR 76861B GR 69089 A GR69089 A GR 69089A GR 820169089 A GR820169089 A GR 820169089A GR 76861 B GR76861 B GR 76861B
- Authority
- GR
- Greece
- Prior art keywords
- compounds
- propoxymethyl
- guanine
- dihydroxy
- reaction
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 5
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
- FCOKLAMVAHWFCI-UHFFFAOYSA-N acetyloxymethoxymethyl acetate Chemical compound CC(=O)OCOCOC(C)=O FCOKLAMVAHWFCI-UHFFFAOYSA-N 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- YMJRISBBXAOKCD-UHFFFAOYSA-N 2-amino-9-(2,3-dihydroxypropoxymethyl)-3h-purin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N(COCC(O)CO)C=N2 YMJRISBBXAOKCD-UHFFFAOYSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 abstract 1
- 229940074076 glycerol formal Drugs 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- QNXFUWFRTWSSOK-UHFFFAOYSA-N n-acetyl-n-(6-oxo-3,7-dihydropurin-2-yl)acetamide Chemical compound O=C1NC(N(C(C)=O)C(=O)C)=NC2=C1NC=N2 QNXFUWFRTWSSOK-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29660481A | 1981-08-26 | 1981-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR76861B true GR76861B (el) | 1984-09-04 |
Family
ID=23142740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR69089A GR76861B (el) | 1981-08-26 | 1982-08-23 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0074306B1 (el) |
| JP (3) | JPS5877881A (el) |
| KR (1) | KR840001168A (el) |
| AT (1) | ATE34750T1 (el) |
| AU (1) | AU8755282A (el) |
| CA (1) | CA1300622C (el) |
| DE (1) | DE3278561D1 (el) |
| DK (1) | DK379782A (el) |
| ES (2) | ES8402837A1 (el) |
| GR (1) | GR76861B (el) |
| IL (1) | IL66640A0 (el) |
| NZ (1) | NZ201662A (el) |
| PT (1) | PT75463B (el) |
| ZA (1) | ZA826196B (el) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5157120A (en) * | 1980-09-16 | 1992-10-20 | Syntex (U.S.A.) Inc. | Guanine derivatives |
| US4347360A (en) * | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
| ES8403128A1 (es) * | 1981-08-11 | 1983-10-01 | Wellcome Found | "un procedimiento para preparar derivados de purina". |
| US4816447A (en) * | 1981-08-26 | 1989-03-28 | Merck & Co., Inc. | Anti-viral guanine compounds |
| US5250535A (en) * | 1982-02-01 | 1993-10-05 | Syntex Inc. | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent |
| JPS58135885A (ja) * | 1982-02-01 | 1983-08-12 | シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド | 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤 |
| US4556659A (en) * | 1982-08-09 | 1985-12-03 | Syntex (U.S.A.) Inc. | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents |
| EP0105486A3 (en) * | 1982-09-30 | 1984-05-16 | Syntex (U.S.A.) Inc. | 1-monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents |
| US4609662A (en) * | 1982-10-14 | 1986-09-02 | Burroughs Wellcome Co. | Method for using purine derivatives |
| US4544634A (en) * | 1982-10-14 | 1985-10-01 | Burroughs Wellcome Co. | Method of producing acyclovir |
| US4462986A (en) * | 1982-11-04 | 1984-07-31 | Ens Bio Logicals, Inc. | Synergistic anti-herpes compositions |
| US5047533A (en) * | 1983-05-24 | 1991-09-10 | Sri International | Acyclic purine phosphonate nucleotide analogs |
| GB2150570B (en) * | 1983-05-24 | 1987-04-08 | Stanford Res Inst Int | Novel antiviral agents |
| IL72173A0 (en) * | 1983-06-24 | 1984-10-31 | Merck & Co Inc | Guanine derivatives,their preparation and pharmaceutical compositions containing them |
| JPS6023380A (ja) * | 1983-06-24 | 1985-02-05 | メルク・エンド・カムパニー・インコーポレーテッド | 抗ウイルス剤 |
| US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
| US4670424A (en) * | 1983-09-19 | 1987-06-02 | Merck & Co., Inc. | Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides |
| US4897479A (en) * | 1983-09-30 | 1990-01-30 | Merck & Co., Inc. | Arylsulfonyloxy purine intermediates |
| EP0138683A3 (en) * | 1983-09-30 | 1988-01-20 | Merck & Co. Inc. | Purine derivatives, their application in anti-viral compositions |
| IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
| DE3571810D1 (en) * | 1984-01-26 | 1989-08-31 | Merck & Co Inc | Substituted butyl guanines and their utilization in antiviral compositions |
| US4579849A (en) * | 1984-04-06 | 1986-04-01 | Merck & Co., Inc. | N-alkylguanine acyclonucleosides as antiviral agents |
| EP0184473A1 (en) * | 1984-10-26 | 1986-06-11 | Merck & Co. Inc. | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives |
| HUT39145A (en) * | 1984-12-12 | 1986-08-28 | Syntex Inc | Process for preparing alkoxy-methyl-ether and alkoxy-methyl ester derivatives |
| SE8406538D0 (sv) | 1984-12-21 | 1984-12-21 | Astra Laekemedel Ab | Novel derivatives of purine |
| CA1330794C (en) * | 1987-03-27 | 1994-07-19 | Phillip Frost | Anti-viral compounds, dosage forms and methods |
| US4966895A (en) * | 1989-02-02 | 1990-10-30 | Merck & Co. Inc. | Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents |
| US5068119A (en) * | 1990-09-28 | 1991-11-26 | Nabisco Brands, Inc. | Acid-hydrolyzable ester derivatives as low calorie fat mimetics |
| GB2260319B (en) | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
| US5532225A (en) * | 1992-07-31 | 1996-07-02 | Sri International | Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods |
| US5565565A (en) * | 1994-08-04 | 1996-10-15 | Syntex (U.S.A.) Inc. | Preparation of N-9 substituted guanine compounds |
| US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| CN1091445C (zh) * | 1999-12-29 | 2002-09-25 | 湖北省医药工业研究院 | 抗病毒药物中间体、它们的制备及应用 |
| EP1565470A2 (en) * | 2002-10-31 | 2005-08-24 | Ranbaxy Laboratories Limited | Process for the preparation of ganciclovir |
| CN113024559B (zh) * | 2019-12-25 | 2022-03-29 | 上药康丽（常州）药业有限公司 | 一种异更昔洛韦的制备方法 |
| KR20240077879A (ko) * | 2022-11-25 | 2024-06-03 | 롯데케미칼 주식회사 | 올레핀 올리고머화의 부산물 저감 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146715A (en) * | 1975-08-27 | 1979-03-27 | Burroughs Wellcome Co. | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
| US4347360A (en) * | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
| US4355032B2 (en) * | 1981-05-21 | 1990-10-30 | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
| ES8403128A1 (es) * | 1981-08-11 | 1983-10-01 | Wellcome Found | "un procedimiento para preparar derivados de purina". |
| JPS58135885A (ja) * | 1982-02-01 | 1983-08-12 | シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド | 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤 |
-
1982
- 1982-08-20 NZ NZ201662A patent/NZ201662A/en unknown
- 1982-08-23 ES ES515193A patent/ES8402837A1/es not_active Expired
- 1982-08-23 GR GR69089A patent/GR76861B/el unknown
- 1982-08-24 DE DE8282401571T patent/DE3278561D1/de not_active Expired
- 1982-08-24 AT AT82401571T patent/ATE34750T1/de not_active IP Right Cessation
- 1982-08-24 EP EP82401571A patent/EP0074306B1/en not_active Expired
- 1982-08-24 AU AU87552/82A patent/AU8755282A/en not_active Abandoned
- 1982-08-25 ZA ZA826196A patent/ZA826196B/xx unknown
- 1982-08-25 IL IL66640A patent/IL66640A0/xx unknown
- 1982-08-25 DK DK379782A patent/DK379782A/da not_active Application Discontinuation
- 1982-08-25 PT PT75463A patent/PT75463B/pt unknown
- 1982-08-25 CA CA000410092A patent/CA1300622C/en not_active Expired - Fee Related
- 1982-08-26 JP JP57147008A patent/JPS5877881A/ja active Granted
- 1982-08-26 KR KR1019820003849A patent/KR840001168A/ko unknown
-
1983
- 1983-05-16 ES ES522456A patent/ES8406547A1/es not_active Expired
-
1991
- 1991-04-16 JP JP3084272A patent/JPH0729979B2/ja not_active Expired - Lifetime
-
1992
- 1992-03-24 JP JP4115111A patent/JPH0714938B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0074306A2 (en) | 1983-03-16 |
| JPH04217940A (ja) | 1992-08-07 |
| ES522456A0 (es) | 1984-08-01 |
| JPS5877881A (ja) | 1983-05-11 |
| ES515193A0 (es) | 1984-03-01 |
| ES8402837A1 (es) | 1984-03-01 |
| ES8406547A1 (es) | 1984-08-01 |
| DK379782A (da) | 1983-02-27 |
| DE3278561D1 (en) | 1988-07-07 |
| NZ201662A (en) | 1986-07-11 |
| EP0074306B1 (en) | 1988-06-01 |
| PT75463B (en) | 1986-08-28 |
| CA1300622C (en) | 1992-05-12 |
| IL66640A0 (en) | 1982-12-31 |
| ZA826196B (en) | 1984-04-25 |
| JPH05286974A (ja) | 1993-11-02 |
| JPH0729979B2 (ja) | 1995-04-05 |
| PT75463A (en) | 1982-09-01 |
| JPH0480914B2 (el) | 1992-12-21 |
| ATE34750T1 (de) | 1988-06-15 |
| AU8755282A (en) | 1983-03-03 |
| KR840001168A (ko) | 1984-03-28 |
| JPH0714938B2 (ja) | 1995-02-22 |
| EP0074306A3 (en) | 1983-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3278561D1 (en) | Anti-viral guanine derivatives | |
| DE3380410D1 (en) | Derivatives of 9-(2-hydroxyethoxymethyl)guanine | |
| EP0206497A3 (en) | Process for the preparation of therapeutic nucleosides | |
| MC1475A1 (fr) | Procede de preparation de derives de la purine a action anti-virale | |
| PT86232A (en) | Process for preparing a pharmaceutical composition containing a9-substituted guanine | |
| AU531266B2 (en) | Preparing derivatives of glyoxylic acid | |
| IT7950847A0 (it) | Derivati amminici dotati di attivi ta' farmacologica e procedimento per la loro preparazione | |
| FR2318137A1 (fr) | Procede de preparation d'ethers perfluores par irradiation lumineuse de perfluoro-cetones | |
| NO143907C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrrolo(1,2-a)-imidazol-derivater | |
| ES456407A1 (es) | Un metodo de preparacion de una purina sustituida. | |
| PT76903A (en) | Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same | |
| BE861325A (fr) | Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments | |
| CA2022323A1 (en) | Excretion of potassium ion by prostanoic acid derivatives | |
| DE3461464D1 (en) | Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them | |
| ES8300747A1 (es) | Procedimiento para la preparacion de derivados de acido in- dolacetico | |
| BE847635A (fr) | Procede de preparation d'ethers dimethyliques de l'hydroquinone, | |
| FR2375184A1 (fr) | Nouveaux derives de l'acide benzoyl phenoxy acetique, leur procede de preparation et leur application en therapeutique | |
| OA05039A (fr) | Procédé de préparation de dérivés actifs d'acide acétique. | |
| BE847271A (fr) | Procede de preparation de l'ester ethylique de l'acide acetique, | |
| GEP19970666B (en) | Process for the preparation of purine derivatives | |
| AR220133Q (es) | Procedimiento de obtencion de preparaciones solidas de medicamentos muy poco solubles,al estado muy finamente dividido | |
| FI882863A (fi) | Foerfarande foer framstaellning av substituerade imidazo (1,5-a) pyridinderivat. | |
| IT7851438A0 (it) | Derivati ad azione terapeutica del la pirimido(2-1-a)isochinolina procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| FR2335209A1 (fr) | Nouveaux derives de l'acide prostanoique, leur procede de preparation et leur application comme medicaments |